Skip to main content

Table 3 Characteristics of two groups divided by purpose of using terlipressin

From: Initial serum sodium concentration determines the decrease in sodium level after terlipressin administration in patients with liver cirrhosis

Characteristics

Bleeding (n = 99)

HRS (n = 28)

p value

Age

57.68 ± 11.24

55.43 ± 11.08

0.918

Sex

  

0.480

 Male (%)

79 (79.8)

24 (85.7)

 

 Female (%)

20 (20.2)

4 (14.3)

 

Etiology of cirrhosis

  

0.967

 Alcoholics (%)

57 (57.6)

16 (57.1)

 

 Non-alcoholics (%)

42 (42.3)

12 (42.9)

 

Infusion of albumin

  

0.009

 Yes (%)

30 (30.3)

16 (57.1)

 

 No (%)

69 (69.7)

12 (42.9)

 

Cumulative dose of Terlipressin (mg)

14.45 ± 3.40

18.50 ± 6.04

0.002

Amount of hydration (L)

4.47 ± 1.92

4.07 ± 2.55

0.450

Amount of sodium infused (mEq)

328.87 ± 285.71

239.74 ± 237.99

0.130

Total bilirubin (0 ~ 1.2 mg/dL)

3.17 ± 4.44

15.83 ± 11.61

0.000

Albumin (3.4 ~ 4.8 g/dL)

2.66 ± 0.52

2.63 ± 0.40

0.767

Creatinine (0.6 ~ 1.2 mg/dL)

1.11 ± 0.50

3.52 ± 2.28

0.000

Hemoglobin (13 ~ 17 g/dL)

8.84 ± 2.39

10.22 ± 1.99

0.003

*PT (0.8 ~ 1.2 *INR)

1.70 ± 0.54

2.05 ± 0.78

0.032

*MELD score

15.13 ± 7.43

33.29 ± 8.90

0.000

*MELD-Na

15.61 ± 11.57

44.36 ± 16.47

0.000

Child-Pugh score (6 ~ 18)

8.19 ± 2.01

11.11 ± 1.85

0.000

Initial sodium (135 ~ 145 mmol/L)

135.74 ± 4.73

128.01 ± 8.29

0.000

Lowest sodium (135 ~ 145 mmol/L)

131.43 ± 5.57

126.73 ± 7.10

0.003

  1. *PT, Prothrombin time; INR, International normalized ratio; MELD, Model for end-stage liver disease; HRS, Hepatorenal syndrome.